The Chulabhorn Royal Academy’s (CRA) plan to import “elective Covid-19 immunizations” from Sinopharm, a Chinese state-claimed organization, on Thursday set off analysis over the public authority’s antibody acquisition plan. The CRA reported an arrangement to obtain elective immunizations to enhance the public authority’s public Covid-19 inoculation drive. The declaration was distributed in the Royal Gazette on Tuesday, and it was …